Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

Major pharmaceutical products and medicines have jumped in prices despite and executive order by President Bola Tinubu, ...

HHS Assistant Secretary of Public Affairs Tom Corry unexpectedly stepped down on Feb. 28. In a brief post on X Monday morning ...

The maiden Fortune India MNC 500 showcases India's largest multinationals, with a cumulative total income of ₹36.77 lakh cr ...

Disney Advertising has announced that it sold out of advertising inventory for the 97th Oscars telecast. The event, hosted ...

Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...

HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...

The US Food and Drug Administration (FDA) has accepted for review GSK’s Biologics License Application for depemokimab.

Vaginitis Treatment Drug MarketThe global vaginitis treatment drug market is projected to grow from USD 3,328.9 million in 2024 to USD 5,320 million by 2034, expanding at a CAGR of 4.8%. This growth ...

CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced its financial results for the fourth quarter and year ...

The higher prices of two COPD inhalers from GSK that are targeted in the second round of government drug price negotiations ...

In the business of drug development, deals can be just as important as scientific breakthroughs. Many of today's most lucrative medicines, from the life-saving cancer treatment Keytruda to the ...